we got a warning letter – now what? how to keep calm in a compliance storm
TRANSCRIPT
#MDOWebinar
#MDOWebinar
q This webinar will be available afterwards at www.medicaldesignandoutsourcing.com & email
q Q&A at the end of the presentation q Hashtag for this webinar: #MDOWebinar
Before We Start
#MDOWebinar
Brian Scogland Consultant II Halloran Consulting Group
Angela Brown Senior Consultant Halloran Consulting Group
Introducing the Featured Speakers
MODERATOR Brian Johnson Publisher Mass Device
FEATURED SPEAKER FEATURED SPEAKER
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
Agenda
Intro to 483 & Warning Letter Remediation
Recent Warning Letter Language
Framework for Response
Framework for Remediation
Summary & Questions
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
Introduction • Medical Device, Biotech, & Pharmaceutical
– all impacted by 483s & warning letters
• Discuss activities necessary to prepare response
to 483 observations or Warning Letter
• Proven actions to help your team stay calm
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
Poll #1
Poll: Which type of organization are you from? – Medical Device – Biotechnology – Pharmaceutical
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
Poll #2
Poll: Which Department are you from? – Executive Management – Regulatory Affairs – Quality Affairs – Operations – Research & Development
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
Does this Sound Familiar? “This inspection revealed that these devices are adulterated…” “We acknowledge your commitment to updating your procedure. However, your response is inadequate…” “Failure to promptly correct these violations may result in regulatory action being initiated by the FDA without further notice. These actions include, but are not limited to, seizure, injunction, and civil money penalties.” “Please notify this office in writing within 15 business days from the date you receive this letter of the specific steps your firm has taken to correct the noted violations, as well as an explanation of how your firm plans to prevent these violations, or similar violations, from occurring again.”
• This could happen to you! – Quality slips over time & remediation is a regular occurrence
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
Lead the response with calm & firm demeanor
• Keeps Management Team supportive • Shows management commitment to compliance • Reflects well with the Agency interactions
Remain the Constant Calm
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
Poll #3
Poll: Have you ever or are you now working at a company operating under a Warning Letter?
– Yes – No
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
You Just got a Warning Letter - Now What?
• Stay poised • Rough order of activities to start the framework:
1. Receive 483 Observation(s) or Warning Letter 2. Preparation 3. Response 4. Review 5. Submission 6. Remediation
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
Whether a 483 or warning letter response, many activities are the same
• Timeline: 15 business days • Comprehensive response • Project plans with due dates • Monthly status updates • Internal & external review of response • Re-establishing FDA’s confidence
Response Overview
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
Where do we start with a response? • Immediately meet with Executive Management
– Review scope of 483 Observation(s) or Warning Letter – Obtain support for priority, resources, etc.
• Meet with functional heads affected – Assign resources – Take response ownership in the response
• Ensure: – Appropriate staffing – Materials, expertise, equipment – Proper legal representation
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
The day after the investigator leaves
• Reserve work space for meetings & response activities
• Gather materials (paper, binders, printers, etc.) • Identify teams (your “go-getters”) • Plan meetings • Prep counsel for reviewing response
Preparation for the Response
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
Crafting the Response
• Ensure timely response! • Empower functional heads • Determine root causes • Generate significant progress in each area in question • Provide objective evidence • Document Corrective Actions
– Include timelines
Important! Failure to demonstrate proof behind any of your stated corrections will lead to more compliance risk – i.e. non-
acceptance, possible additional regulatory action (Warning Letter, Consent Decree)
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
Remediation – What to Expect
• Expensive and often large projects – 6 months to a year+
• Drag on business initiatives & development projects • Loss of resources
• Opportunity to shine!! – FDA, Management, and Staff
• Demonstrate leadership attributes
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
Remediation – First Steps
The day after the response is sent • Are you staffed to deliver the remediation?
– Meet with Executive Management, HR – Strong Project Managers
• Focus on resources is in place vs. what is needed – Expertise may be lacking in-house – Consider outside resources
• Do you need to retain key individuals?
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
Remediation Process
• Formally launch a project with Workstreams and Workstream Leads
• Create Project plan with intermediate and final deadlines
• Track progress religiously
• Meet frequently
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
• Increased scrutiny from other regulatory agencies
• Potential limitations to distribution channels
• Marketplace disruption
Additional Impacts from a Warning Letter
Proprietary & Confidential Proprietary & Confidential #MDOWebinar
Response • Remain calm • Plan out your initial timeline: 15 Days • Well thought out & comprehensive response
Remediation • Prepare for long term • Resourcing critical • Strong leadership
Summary
#MDOWebinar
Questions?
Brian Scogland Consultant II Halloran Consulting Group [email protected] @scogs30
Angela Brown Senior Consultant Halloran Consulting Group [email protected]
#MDOWebinar
q This webinar will be available at www.medicaldesignandoutsourcing.com & email
q Tweet us! #MDOwebinar
q Connect with Medical Design & Outsourcing
q Discuss this on EngineeringExchange.com
Don’t Forget!
#MDOWebinar
THANK YOU!